BRO vs OGEN · P/E 30, rev $4.80B vs rev $37.7K
Brown & Brown Inc (BRO) versus Oragenics Inc (OGEN) — a side-by-side from cached financials, not a winner call.
Brown & Brown Inc (BRO) is a insurance brokers company listed on US.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Latest reported BRO revenue for 2024-12-31 was $4.80B. Net income was $1.00B. Revenue was up 12.9% from 2023-12-31 to 2024-12-31. BRO currently screens at market cap $35.56B and trailing P/E 30.0.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
BRO currently screens at market cap $35.56B and trailing P/E 30.0. OGEN currently screens at market cap $2.7M.
Not investment advice. Open the BRO and OGEN stock pages for the full models.
Not investment advice.